{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3258, 
        3264
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3355, 
        3361
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3265, 
        3274
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3362, 
        3371
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3134, 
        3157
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3491, 
        3511
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3689, 
        3709
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3180, 
        3207
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3224, 
        3228
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3313, 
        3317
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3441, 
        3445
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3464, 
        3468
      ]
    }
  ], 
  "Lymphatic System Location (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3318, 
        3337
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3469, 
        3488
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2205, 
        2234
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3397, 
        3423
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3249, 
        3257
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3344, 
        3354
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3229, 
        3235
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3446, 
        3452
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3209, 
        3211
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3310, 
        3312
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3425, 
        3427
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3460, 
        3462
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 3^9999^MOH|PIMS|CCO|20160504053110|E609C68649120188376C23A02EAA766E35BC2571|ORU^R01|99999999999|P|2.5|||||||||||\nPID|1||Y9999999^^^^CMR^HOSPITAL 3&9999&MOH~Y9999999^^^^MRN^HOSPITAL 3&9999&MOH~9999999999&RC&ON^^^^JHN||XXXXXXXXX^XXXXXX^ XXXXX^^^^||99999999|F|||99 XXXXXXXXX XXX^^XXXXX XXXX^XX^X9X 9X9^999|||||||||||||||||||N|||||||||||\nOBR|1||SC3652-16|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160331|||65227^XXXXX^XXXXXX^XXX^^^^||||||||||||20160503|||C|||||||99999^XX-XXXXXXX^XXXX^XXXXXXX XXXXX^^^^|||||||||||||||||||\n\n\n\n\n\n\n\nPath Report.addendum spec\n\nBIOMARKERS PATHOLOGY CONSULTATION REPORT\nDIAGNOSIS\nCore biopsy left breast nodule - SC3652-16:\nSEE SYNOPTIC REPORT AND COMMENT\nCOMMENT: As the carcinomas from both breast and axillary core biopsy specimens are\nnegative for ER, PR nad HERS, repeating breast biomarkers on excisinal specimen is\nrecommended.\nSpecimen\nSpecimen #:          SC3652-16\nSpecimen Type:        Other: A1: Breast core\n                   B1: Axillary lymph node core\nTumour 1          \nBlock #:           A1\nTumour Type:         Other: Mostly detached fragments of carcinoma\nER\n   ER Results:       NEGATIVE\nPgR\n   PgR Results:       MEGATIVE\nHER2 by IHC\n   HER2 IHC Results:    NEGATIVE (SCORE 0)\nControls\n   ER Test Control Status: Internal controls absent\n   PgR Test control Status: Internal controls absent\nTumour 2\nBlock (2) #:            B1\nTumour Type:            Metastatic carcinoma\nER - Tumour 2\n   ER Results (2):        NEGATIVE\n  \nPgR - Tumour 2\n   PgR Results (2):       NEGATIVE\nHER2 by IHC - Tumour 2\n   HER2 IHC Results (2):     NEGATIVE (SCORE 0)\nControls - Tumour 2\n   ER Test Control Status (2):  Internal controls absent\n   PgR Test control Status (2): Internal controls absent\nMethods\nCold Ischemia and Fixation Times Meet the requirements Specified in the Latest\nVersion of the ASCO/CAP Guidelines: Yes\n   Fixative:          Formalin\n   Primary Antibody - ER:   SP1 (Health Canada approved)\n   Primary Antibody - PgR:   16 (Health Canada approved)\n   Primary Antibody - Her2:  4B5 (Health Canada approved)\nFor details, please see consultation report B16-873 (dated 4/20/2016) by Dr. Fang-I\nLu at HOSPITAL 2.\n\n\nPath report.gross description\n\nA: The specimen is labeled with the patient`s identification, submitted as\n\"ultrasound-guided core biopsy of left breast nodule\" and consists of 2 cores of\ntan-brown soft tissue measuring up to 1.0 cm in length and 0.2 cm in diameter. Also\nidentified in the specimen container are multiple fragments of smaller tissue\nmeasuring up to 0.3 cm. The specimen is submitted in toto as follows:\nA1 and A2: One O/block\nA3: Multiple fragments\n\nB: The specimen is labeled with the patient`s identification, submitted as\n\"ultrasound-guided guided core biopsy of left axillary lymph node\" and consists of 4\ncores and the 4 smaller fragments of tan soft tissue measuring up to 1.1 cm in length\nand less than 0.1 cm in maximum external diameter. The specimen is submitted in toto\nas follows:\nB1 to B4: One core/block\nB5: 4 smaller fragments\n/LG\nIschemic time: Less than 1 hour\nTissue fixation time: 8-24 hours\n\n\nPath report.relevant Hx\n\nLEFT BREAST NODULE\n\n\nPath report.final diagnosis\n\nA. CORE BIOPSY LEFT BREAST NODULE:\n   - INVASIVE DUCTAL CARCINOMA WITH APOCRINE FEATURES, HIGH-GRADE\nB. LEFT AXILLARY LYMPH NODE:\n   - METASTATIC DUCTAL CARCINOMA WITH APOCRINE FEATURES\n\n\nPath report.site of origin\n\nA.  CORE BIOPSY LEFT BREAST NODULE\nB.  LEFT AXILLARY LYMPH NODE\n\n\nPath report.comments\n\nThis case has been peer reviewed; the above diagnosis is a consensus.\n\nBlock A1 will be sent for hormonal biomarkers to HOSPITAL 12, results will\nbe reported as an addendum.\n\n\nPath report.comments\n\n1\n\n\n"
}